| Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND FP Brouwers, RA de Boer, P van der Harst, AA Voors, RT Gansevoort, ... European heart journal 34 (19), 1424-1431, 2013 | 688 | 2013 |
| Predicting heart failure with preserved and reduced ejection fraction: the international collaboration on heart failure subtypes JE Ho, D Enserro, FP Brouwers, JR Kizer, SJ Shah, BM Psaty, TM Bartz, ... Circulation: Heart Failure 9 (6), e003116, 2016 | 326 | 2016 |
| Association of cardiovascular biomarkers with incident heart failure with preserved and reduced ejection fraction RA De Boer, M Nayor, CR DeFilippi, D Enserro, V Bhambhani, JR Kizer, ... JAMA cardiology 3 (3), 215-224, 2018 | 242 | 2018 |
| Sex differences in new-onset heart failure S Meyer, FP Brouwers, AA Voors, HL Hillege, RA de Boer, RT Gansevoort, ... Clinical Research in Cardiology 104, 342-350, 2015 | 152 | 2015 |
| Predictors and outcomes of heart failure with mid‐range ejection fraction V Bhambhani, JR Kizer, JAC Lima, P Van Der Harst, H Bahrami, M Nayor, ... European journal of heart failure 20 (4), 651-659, 2018 | 148 | 2018 |
| Clinical risk stratification optimizes value of biomarkers to predict new-onset heart failure in a community-based cohort FP Brouwers, WH van Gilst, K Damman, MP van den Berg, ... Circulation: Heart Failure 7 (5), 723-731, 2014 | 101 | 2014 |
| Serial galectin-3 and future cardiovascular disease in the general population AR van der Velde, WC Meijers, JE Ho, FP Brouwers, M Rienstra, ... Heart 102 (14), 1134-1141, 2016 | 68 | 2016 |
| Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria: ten years of follow-up of Prevention of Renal and Vascular End-stage … FP Brouwers, FW Asselbergs, HL Hillege, RA de Boer, RT Gansevoort, ... American heart journal 161 (6), 1171-1178, 2011 | 65 | 2011 |
| Genome-wide association study on plasma levels of midregional-proadrenomedullin and C-terminal-pro-endothelin-1 N Verweij, H Mahmud, IM Leach, RA de Boer, FP Brouwers, H Yu, ... Hypertension 61 (3), 602-608, 2013 | 56 | 2013 |
| Comparing new onset heart failure with reduced ejection fraction and new onset heart failure with preserved ejection fraction: an epidemiologic perspective FP Brouwers, HL Hillege, WH van Gilst, DJ van Veldhuisen Current heart failure reports 9, 363-368, 2012 | 51 | 2012 |
| Heart failure with preserved and reduced ejection fraction: different risk profiles for different diseases BA Borlaug European heart journal 34 (19), 1393-1395, 2013 | 46 | 2013 |
| Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population FP Brouwers, RA de Boer, P van der Harst, J Struck, PE de Jong, ... Heart 98 (18), 1348-1353, 2012 | 44 | 2012 |
| Urinary potassium excretion and risk of cardiovascular events LM Kieneker, RT Gansevoort, RA de Boer, FP Brouwers, EJM Feskens, ... The American Journal of Clinical Nutrition 103 (5), 1204-1212, 2016 | 38 | 2016 |
| Heart failure and inflammation-related biomarkers as predictors of new-onset diabetes in the general population N Suthahar, WC Meijers, FP Brouwers, HJL Heerspink, RT Gansevoort, ... International journal of cardiology 250, 188-194, 2018 | 37 | 2018 |
| Hemoglobin levels and new-onset heart failure in the community IJT Klip, D Postmus, AA Voors, FPJ Brouwers, RT Gansevoort, SJL Bakker, ... American heart journal 169 (1), 94-101. e2, 2015 | 30 | 2015 |
| Plasma calcidiol, calcitriol, and parathyroid hormone and risk of new onset heart failure in a population‐based cohort study LMG Meems, FP Brouwers, MM Joosten, HJ Lambers Heerspink, ... ESC Heart Failure 3 (3), 189-197, 2016 | 24 | 2016 |
| Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium M Bahls, MW Lorenz, M Dörr, L Gao, K Kitagawa, TP Tuomainen, ... European journal of preventive cardiology 27 (3), 234-243, 2020 | 19 | 2020 |
| Elevated urinary albumin excretion complements the Framingham Risk Score for the prediction of cardiovascular risk—response to treatment in the PREVEND IT trial FP Brouwers, FW Asselbergs, HL Hillege, RT Gansevoort, RA de Boer, ... IJC Heart & Vessels 4, 193-197, 2014 | 4 | 2014 |
| The changing face of heart failure: are we really making progress FP Brouwers, WH van Gilst, DJ van Veldhuisen Eur. J. Heart Fail 15, 960-962, 2013 | 4 | 2013 |
| Association of cardiovascular biomarkers with incident heart failure with preserved and reduced ejection fraction. JAMA Cardiol 3 (3): 215–24 RA de Boer, M Nayor, CR deFilippi, D Enserro, V Bhambhani, JR Kizer, ... | 3 | 2018 |
Folkert AsselbergsCardiologist, Amsterdam University Medical Center, Netherlands在 amsterdamumc.nl 的电子邮件经过验证
